Bayesian adaptive trial designs for precision medicine

Redesigning clinical trials in the era of precision medicine

Synthetic lethality as a basis to select drug combinations

Patient-specific peptide vaccines

Proteogenomics in cancer research

Novel models to personalise cancer therapeutics

Benefits of skin and nipple saving mastectomy

Low dose exemestane usage in breast cancer

BRCA1 and BRCA2 genes and hereditary breast cancers

The Umberto Veronesi Milan Breast Cancer Conference

4 years of RESONATE data for CLL patients treated with ibrutinib

Hemcare - multiple myeloma learning programme